Suppression of Major Histocompatibility Complex (MHC) Class I and II Mediates Resistance to Anti-PD-1 in Lung Adenocarcinoma Tumors That Can Be Overcome by Radiation Therapy Conference

Wang, X, Schoenhals, JE, Valdecanas, DR et al. (2016). Suppression of Major Histocompatibility Complex (MHC) Class I and II Mediates Resistance to Anti-PD-1 in Lung Adenocarcinoma Tumors That Can Be Overcome by Radiation Therapy . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), S89-S89. 10.1016/j.ijrobp.2016.06.224

cited authors

  • Wang, X; Schoenhals, JE; Valdecanas, DR; Li, A; Ye, H; Zhang, F; Tang, M; Tang, C; Liu, CG; Liu, X; Komaki, RU; Gomez, DR; Chang, JY; Cortez, MA; Welsh, JW

authors

date/time interval

  • September 25, 2016 -

publication date

  • October 1, 2016

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • MA, Boston

Digital Object Identifier (DOI)

Conference

  • 58th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • S89

end page

  • S89

volume

  • 96

issue

  • 2